Relief Therapeutics Holding AG (RLF.SW)

CHF 2.55

(2.41%)

Total Assets Summary of Relief Therapeutics Holding AG

Relief Therapeutics Holding AG's latest annual total assets in 2023 was 76.39 Million CHF , down -59.54% from previous year.
Relief Therapeutics Holding AG's latest quarterly total assets in 2024 Q2 was 70.92 Million CHF , down 0.0% from previous quarter.
Relief Therapeutics Holding AG reported annual total assets of 188.79 Million CHF in 2022, down -24.97% from previous year.
Relief Therapeutics Holding AG reported annual total assets of 251.61 Million CHF in 2021, up 222.4% from previous year.
Relief Therapeutics Holding AG reported quarterly total assets of 76.39 Million CHF for 2023 Q4, down 0.0% from previous quarter.
Relief Therapeutics Holding AG reported quarterly total assets of 76.39 Million CHF for 2023 FY, down -59.54% from previous quarter.

Annual Total Assets Chart of Relief Therapeutics Holding AG (2023 - 2007)

Historical Annual Total Assets of Relief Therapeutics Holding AG (2023 - 2007)

Year	Total Assets	Total Assets Growth
2023	76.39 Million CHF	-59.54%
2022	188.79 Million CHF	-24.97%
2021	251.61 Million CHF	222.4%
2020	78.04 Million CHF	292.92%
2019	19.86 Million CHF	-44.17%
2018	35.57 Million CHF	14.87%
2017	30.97 Million CHF	-1.44%
2016	31.42 Million CHF	4.28%
2015	30.13 Million CHF	-27.6%
2014	41.62 Million CHF	-9.48%
2013	45.98 Million CHF	3471.27%
2012	1.28 Million CHF	-60.71%
2011	3.27 Million CHF	-94.38%
2010	58.3 Million CHF	-10.6%
2009	65.21 Million CHF	-14.93%
2008	76.66 Million CHF	-3.12%
2007	79.13 Million CHF	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	70.92 Million CHF	0.0%
2023 Q4	76.39 Million CHF	0.0%
2023 FY	76.39 Million CHF	-59.54%
2023 Q2	125.77 Million CHF	0.0%
2022 FY	188.79 Million CHF	-24.97%
2022 Q4	188.79 Million CHF	0.0%
2022 Q2	221.82 Million CHF	0.0%
2021 FY	251.61 Million CHF	222.4%
2021 Q2	179.98 Million CHF	0.0%
2021 Q4	251.61 Million CHF	0.0%
2020 FY	78.04 Million CHF	292.92%
2020 Q4	78.04 Million CHF	0.0%
2020 Q2	34.34 Million CHF	0.0%
2019 Q2	31.04 Million CHF	0.0%
2019 FY	19.86 Million CHF	-44.17%
2019 Q4	19.86 Million CHF	0.0%
2018 Q4	35.57 Million CHF	0.0%
2018 Q2	35.4 Million CHF	0.0%
2018 FY	35.57 Million CHF	14.87%
2017 FY	30.97 Million CHF	-1.44%
2017 Q4	30.97 Million CHF	0.0%
2017 Q2	31.19 Million CHF	0.0%
2016 Q4	31.42 Million CHF	0.0%
2016 Q2	22.87 Million CHF	0.0%
2016 FY	31.42 Million CHF	4.28%
2015 Q4	30.13 Million CHF	0.0%
2015 Q2	31.57 Million CHF	0.0%
2015 FY	30.13 Million CHF	-27.6%
2014 Q2	41.57 Million CHF	0.0%
2014 FY	41.62 Million CHF	-9.48%
2014 Q4	41.62 Million CHF	0.0%
2013 FY	45.98 Million CHF	3471.27%
2013 Q4	45.98 Million CHF	0.0%
2013 Q2	1.09 Million CHF	0.0%
2012 Q4	1.28 Million CHF	0.0%
2012 FY	1.28 Million CHF	-60.71%
2012 Q2	1.33 Million CHF	0.0%
2011 Q2	11.97 Million CHF	0.0%
2011 Q4	3.27 Million CHF	0.0%
2011 FY	3.27 Million CHF	-94.38%
2010 Q2	61.85 Million CHF	0.0%
2010 FY	58.3 Million CHF	-10.6%
2010 Q4	58.3 Million CHF	0.0%
2009 Q4	65.21 Million CHF	0.0%
2009 FY	65.21 Million CHF	-14.93%
2009 Q2	76.8 Million CHF	0.0%
2008 FY	76.66 Million CHF	-3.12%
2008 Q4	76.66 Million CHF	0.0%
2007 FY	79.13 Million CHF	0.0%

Peer Total Assets Comparison of Relief Therapeutics Holding AG

Name	Total Assets	Total Assets Difference
Addex Therapeutics Ltd	4.64 Million CHF	-1545.968%
BB Biotech AG	2.63 Billion CHF	97.103%
Basilea Pharmaceutica AG	173.28 Million CHF	55.918%
Evolva Holding SA	9.82 Million CHF	-677.253%
Idorsia Ltd	499.99 Million CHF	84.722%
Kuros Biosciences AG	75.9 Million CHF	-0.638%
Molecular Partners AG	198.35 Million CHF	61.488%
Santhera Pharmaceuticals Holding AG	109.62 Million CHF	30.32%